S2B GmbH & Co. KG develops innovative and sustainable processes for the biotechnological production of mushroom-based meat alternatives and active ingredients for the pharmaceutical and cosmetics industries. The company focuses on strain development and fermentation, harnessing the potential of highly efficient fungi and microalgae. At its Ahlhorn site, S2B operates a well-equipped S1 laboratory and maintains bioreactor capacities at both laboratory and pilot scale.
Our vision is to create highly efficient platform technologies for a wide range of applications in the biotechnology industry, enabling our customers to produce more efficiently and in a resource-conserving manner.